Analytical Data
-
Gene name
Clec2f
- Application
-
Alternative Names
C-type lectin domain family 2 member F; Clec2f; C-type lectin-related protein C (Clr-c); Clrc
-
Species
Mouse
-
Source
HEK293
-
Tag
C-hFc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8VI21-1
-
Expression Region
T63-C196
-
Molecular Weight
53-63 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Clec2f, or C-type lectin domain family 2 member F, is a member of the C-type lectin superfamily and plays an essential role in the immune response. Found predominantly in dendritic cells and macrophages, Clec2f has garnered attention for its involvement in the recognition of pathogens and the modulation of immune signaling pathways. Emerging research highlights its significance in both innate and adaptive immunity, revealing that Clec2f can influence cellular activation, differentiation, and cytokine production. Given its potential as a biomarker for immune-related diseases, including infections and autoimmune disorders, the study of Clec2f recombinant protein is increasingly relevant. Researchers are exploring its structure-function relationships, which could elucidate its mechanisms of action, and this knowledge may guide the development of novel therapeutics. Furthermore, Clec2f’s ability to facilitate the uptake of glycan-coated particles positions it as a promising target for vaccine development, enhancing antigen presentation and improving vaccine efficacy. Understanding the intricacies of Clec2f’s role in the immune system is critical, as it may lead to breakthroughs in controlling various diseases and informing strategies for immunotherapy. Consequently, the recombinant production of Clec2f not only serves as a vital tool for basic research but also holds promise for translational applications in medicine.
